Nikola Pokrivač, a former Croatia national team midfielder who played at the 2008 European Championship, has died in a car ...

Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of ...

RIKEN researchers have discovered how a single mutation in one gene can simultaneously result in two symptoms—a severely ...

Nonsquamous histology correlated with improved survival. Fourteen of the 15 patients surviving more than 24 months and all 9 patients surviving more than 30 months had nonsquamous tumors. Immunologic ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard therapy for patients with chronic lymphocytic leukemia (CLL ...

HealthDay News — Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocytic scarring alopecias, according to a research letter published online ...

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL. Venetoclax-containing regimens demonstrated superior ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for extensive-stage small cell lung cancer. The PD-L1 and VEGF-A bispecific antibody ...

1 Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull, United Kingdom 2 Department of Haematology, Castle ...